The development of IBD is dependent upon the activation of mucosal leukocyte populations and the production of inflammatory mediators. The central hypothesis of this center's research program presumes that leukocytes are activated following induced disruption of the mucosal barrier in conjunction with intrinsic genetically determined abnormalities of regulatory mechanisms. In order to effectively define the mechanisms contributing to IBD, it is essential that center investigators have the tools necessary to obtain immune cell populations, determine their functional properties and assess production of key mediators. Although the CSIBD research base encompasses many investigators exploring mechanisms of immune responsiveness in their laboratories, the Immunology Core offers cost-effective service while providing access to these techniques (by service and/or training) to laboratories not focused on these approaches in their primary research orientation. The specific services offered to CSIBD investigators include: 1. Flow cytometry 2. Leukocyte isolation and cell sorting 3. Multiplex cytokine assays 4. T and B lymphocyte functional assays 5. Intravital imaging of immune cells in vivo The Immunology Core assists investigators in developing assays and offers in-depth training in a number of newly developing, powerful immunologic techniques. It also provides a mechanism to support the efforts of many CSIBD Pilot/Feasibility award recipients and establish collaborations among CSIBD investigators. The Immunology Core has been highly effective in achieving its several goals of providing effective service that both facilitates research and reduces research costs, while enabling CSIBD investigators, associate investigators and personnel in their laboratories to develop and apply immunologic techniques to their research as well to foster collaborations that enhance the mission of the center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK043351-24
Application #
8583313
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
24
Fiscal Year
2014
Total Cost
$113,135
Indirect Cost
$50,452
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Yassour, Moran; Jason, Eeva; Hogstrom, Larson J et al. (2018) Strain-Level Analysis of Mother-to-Child Bacterial Transmission during the First Few Months of Life. Cell Host Microbe 24:146-154.e4
Akcakaya, Pinar; Bobbin, Maggie L; Guo, Jimmy A et al. (2018) In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature 561:416-419
Kim, Byeong-Moo; Abdelfattah, Ahmed Maher; Vasan, Robin et al. (2018) Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. Sci Rep 8:7499
Burke, Kristin E; Ananthakrishnan, Ashwin N; Lochhead, Paul et al. (2018) Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. J Crohns Colitis 12:559-567
Perugino, Cory A; AlSalem, Sultan B; Mattoo, Hamid et al. (2018) Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol :
Yurchenko, Maria; Skjesol, Astrid; Ryan, Liv et al. (2018) SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages. J Cell Biol 217:1411-1429
Kim, Young-In; Song, Joo-Hye; Ko, Hyun-Jeong et al. (2018) CX3CR1+ Macrophages and CD8+ T Cells Control Intestinal IgA Production. J Immunol 201:1287-1294
Ma, Wenjie; Jovani, Manol; Liu, Po-Hong et al. (2018) Association Between Obesity and Weight Change and Risk of Diverticulitis in Women. Gastroenterology 155:58-66.e4
Moretti, Francesca; Bergman, Phil; Dodgson, Stacie et al. (2018) TMEM41B is a novel regulator of autophagy and lipid mobilization. EMBO Rep 19:
DeBoever, Christopher; Tanigawa, Yosuke; Lindholm, Malene E et al. (2018) Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study. Nat Commun 9:1612

Showing the most recent 10 out of 1166 publications